• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prehospital Clopidogrel Administration in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary PCI: Real-Life Experience From the Multicenter NRDES Registry.

作者信息

Rakowski Tomasz, Siudak Zbigniew, Dziewierz Artur, Sawina Agata, Dudek Dariusz

机构信息

2nd Department of Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Kopernika 17 Street, 31-501 Krakow, Poland.

出版信息

J Invasive Cardiol. 2016 Jun;28(6):E56-8.

PMID:27236013
Abstract
摘要

相似文献

1
Prehospital Clopidogrel Administration in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary PCI: Real-Life Experience From the Multicenter NRDES Registry.ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗时院前给予氯吡格雷：多中心NRDES注册研究的真实世界经验
J Invasive Cardiol. 2016 Jun;28(6):E56-8.
2
Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).根据经皮冠状动脉介入治疗的时间，替格瑞洛与氯吡格雷在 ST 段抬高型心肌梗死患者中的疗效比较：TRITON-TIMI 38 亚组分析（评估通过优化血小板抑制改善治疗结果的试验：替格瑞洛在心肌梗死中的疗效 38）。
JACC Cardiovasc Interv. 2014 Jun;7(6):604-12. doi: 10.1016/j.jcin.2014.01.160.
3
Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry.普通肝素、依诺肝素或比伐卢定院前给药对接受ST段抬高型心肌梗死直接经皮冠状动脉介入治疗患者的疗效及安全性：来自ORBI注册研究的见解
Arch Cardiovasc Dis. 2016 Dec;109(12):696-707. doi: 10.1016/j.acvd.2015.10.007. Epub 2016 Nov 3.
4
Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]).接受普拉格雷或氯吡格雷经皮冠状动脉介入治疗患者的治疗模式和结局（来自瑞典冠状动脉造影和血管成形术登记处[SCAAR]）。
Am J Cardiol. 2014 Jan 1;113(1):64-9. doi: 10.1016/j.amjcard.2013.09.019. Epub 2013 Oct 3.
5
Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.在ST段抬高型心肌梗死的经皮冠状动脉介入治疗期间，不同抗血小板治疗方案后实现的血小板聚集抑制。
J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93. doi: 10.1016/j.jacc.2004.06.050.
6
Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary intervention.氯吡格雷预处理在 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗中的应用。
Am Heart J. 2010 Jul;160(1):202-7. doi: 10.1016/j.ahj.2010.04.018.
7
Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction.噻吩吡啶（氯吡格雷或普拉格雷）预处理对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的抗血小板作用。
Am J Cardiol. 2013 Nov 15;112(10):1551-6. doi: 10.1016/j.amjcard.2013.07.010. Epub 2013 Aug 22.
8
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).PLATO 试验（血小板抑制和患者结局）的血管造影结局。
JACC Cardiovasc Interv. 2013 Jul;6(7):671-83. doi: 10.1016/j.jcin.2013.03.014.
9
Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.标准与高负荷剂量氯吡格雷在亚洲 ST 段抬高型心肌梗死患者行经皮冠状动脉介入治疗中的应用：来自韩国急性心肌梗死注册研究的启示。
Am Heart J. 2011 Feb;161(2):373-382.e1-3. doi: 10.1016/j.ahj.2010.10.031. Epub 2011 Jan 15.
10
MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.对接受直接血管成形术并同时使用普拉格雷或氯吡格雷进行上游抗血小板治疗的ST段抬高型心肌梗死患者的多国非干预性研究——欧洲MULTIPRAC注册研究
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):220-9. doi: 10.1177/2048872614547449. Epub 2014 Sep 2.

引用本文的文献

1
The influence of pre-hospital medication administration in ST-elevation myocardial infarction patients on left ventricular ejection fraction and intra-hospital death.院前用药对ST段抬高型心肌梗死患者左心室射血分数及院内死亡的影响。
Postepy Kardiol Interwencyjnej. 2021 Mar;17(1):39-45. doi: 10.5114/aic.2021.104766. Epub 2021 Mar 27.
2
Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction.接受直接经皮冠状动脉介入治疗的心肌梗死溶栓治疗III级血流患者的发生率：并非所有罪犯血管在ST段抬高型心肌梗死中均完全闭塞。
Cureus. 2020 Dec 12;12(12):e12036. doi: 10.7759/cureus.12036.
3
Contemporary use of P2Y inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry.
当代波兰 ST 段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时对 P2Y 抑制剂的应用：来自 ORPKI 全国注册研究的数据。
J Thromb Thrombolysis. 2018 Jan;45(1):151-157. doi: 10.1007/s11239-017-1579-9.